Continuous or discontinuous tranexamic acid effectively inhibits fibrinolysis in children undergoing cardiac surgery with cardiopulmonary bypass

Blood Coagulation and Fibrinolysis

Volumn 25, Issue 3, 2014, Pages 259-265

  Couturier, Roland ^a   Rubatti, Marina ^a   Credico, Carmen ^a   Louvain Quintard, Virginie ^a   Anerkian, Vregina ^a   Doubine, Sylvie ^a   Vasse, Marc ^b   Grassin Delyle, Stanislas ^b,c  

^a CENTRE CHIRURGICAL MARIE LANNELONGUE   (France)

^b FOCH HOSPITAL   (France)

^c RAYMOND POINCARÉ HOSPITAL   (France)

Author keywords

Cardiac surgery; Cardiopulmonary bypass; Children; Fibrinolysis; Tranexamic acid

Indexed keywords

D DIMER; FIBRIN MONOMER; FIBRINOGEN; PLASMINOGEN; PLASMINOGEN ACTIVATOR INHIBITOR 1; TISSUE PLASMINOGEN ACTIVATOR; TRANEXAMIC ACID; ANTIFIBRINOLYTIC AGENT;

ARTICLE; BLEEDING; BLOOD SAMPLING; BLOOD TRANSFUSION; CARDIOPULMONARY BYPASS; CHILD; CLINICAL ARTICLE; CONGENITAL HEART DISEASE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG WITHDRAWAL; FEMALE; FIBRIN FORMATION; FIBRINOLYSIS; HEART SURGERY; HUMAN; MALE; PARTIAL THROMBOPLASTIN TIME; PEDIATRIC SURGERY; PRIORITY JOURNAL; PROTHROMBIN TIME; RANDOMIZED CONTROLLED TRIAL; STERNOTOMY; BLOOD; BLOOD LOSS, SURGICAL; DRUG ADMINISTRATION; INFANT; PRESCHOOL CHILD; PROCEDURES;

ANTIFIBRINOLYTIC AGENTS; BLOOD LOSS, SURGICAL; CARDIAC SURGICAL PROCEDURES; CARDIOPULMONARY BYPASS; CHILD; CHILD, PRESCHOOL; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; INFANT; MALE; TRANEXAMIC ACID;

EID: 84897573510     PISSN: 09575235     EISSN: 14735733     Source Type: Journal    
DOI: 10.1097/MBC.0000000000000051     Document Type: Article

References (38)

1. McEwan A. Aspects of bleeding after cardiac surgery in children. Paediatr Anaesth 2007; 17:1126-1133
2. Petaja J, Lundstrom U, Leijala M, Peltola K, Siimes MA. Bleeding and use of blood products after heart operations in infants. J Thorac Cardiovasc Surg 1995; 109:524-529
3. Paparella D, Brister SJ, Buchanan MR. Coagulation disorders of cardiopulmonary bypass: A review. Intensive Care Med 2004; 30:1873-1881
4. Levin E, Wu J, Devine DV, Alexander J, Reichart C, Sett S, et al. Hemostatic parameters and platelet activation marker expression in cyanotic and acyanotic pediatric patients undergoing cardiac surgery in the presence of tranexamic acid. Thromb Haemost 2000; 83:54-59
5. Guay J, Ruest P, Lortie L. Cardiopulmonary bypass induces significant platelet activation in children undergoing open-heart surgery. Eur J Anaesthesiol 2004; 21:953-956
6. Eisses MJ, Chandler WL. Cardiopulmonary bypass parameters and hemostatic response to cardiopulmonary bypass in infants versus children. J Cardiothorac Vasc Anesth 2008; 22:53-59
7. Williams GD, Bratton SL, Nielsen NJ, Ramamoorthy C. Fibrinolysis in pediatric patients undergoing cardiopulmonary bypass. J Cardiothorac Vasc Anesth 1998; 12:633-638
8. Chan AK, Leaker M, Burrows FA, Williams WG, Gruenwald CE, Whyte L, et al. Coagulation and fibrinolytic profile of paediatric patients undergoing cardiopulmonary bypass. Thromb Haemost 1997; 77:270-277
9. Hartmann M, Sucker C, Boehm O, Koch A, Loer S, Zacharowski K. Effects of cardiac surgery on hemostasis. Transfus Med Rev 2006; 20:230-241
10. Albisetti M. The fibrinolytic system in children. Semin Thromb Hemost 2003; 29:339-348
11. Kern FH, Morana NJ, Sears JJ, Hickey PR. Coagulation defects in neonates during cardiopulmonary bypass. Ann Thorac Surg 1992; 54:541-546
12. Kuhle S, Male C, Mitchell L. Developmental hemostasis: Pro- And anticoagulant systems during childhood. Semin Thromb Hemost 2003; 29:329-338
13. Guay J, Rivard GE. Mediastinal bleeding after cardiopulmonary bypass in pediatric patients. Ann Thorac Surg 1996; 62:1955-1960
14. Fergusson DA, Hebert PC,Mazer CD, Fremes S, MacAdams C, Murkin JM, et al. A comparison of aprotinin and lysine analogues in high-risk cardiac surgery. N Engl J Med 2008; 358:2319-2331
15. Dunn CJ, Goa KL. Tranexamic acid: A review of its use in surgery and other indications. Drugs 1999; 57:1005-1032
16. Soslau G, Horrow J, Brodsky I. Effect of tranexamic acid on platelet ADP during extracorporeal circulation. Am J Hematol 1991; 38:113-119
17. Bulutcu FS, Ozbek U, Polat B, Yalcin Y, Karaci AR, Bayindir O. Which may be effective to reduce blood loss after cardiac operations in cyanotic children: Tranexamic acid, aprotinin or a combination̈ Paediatr Anaesth 2005; 15:41-46
18. Reid RW, Zimmerman AA, Laussen PC, Mayer JE, Gorlin JB, Burrows FA. The efficacy of tranexamic acid versus placebo in decreasing blood loss in pediatric patients undergoing repeat cardiac surgery. Anesth Analg 1997; 84:990-996
19. Shimizu K, Toda Y, Iwasaki T, Takeuchi M, Morimatsu H, Egi M, et al. Effect of tranexamic acid on blood loss in pediatric cardiac surgery: A randomized trial. J Anesth 2011; 25:823-830
20. Chauhan S, Bisoi A, Kumar N, Mittal D, Kale S, Kiran U, et al. Dose comparison of tranexamic acid in pediatric cardiac surgery. Asian Cardiovasc Thorac Ann 2004; 12:121-124
21. Chauhan S, Das SN, Bisoi A, Kale S, Kiran U. Comparison of epsilon aminocaproic acid and tranexamic acid in pediatric cardiac surgery. J Cardiothorac Vasc Anesth 2004; 18:141-143
22. Giordano R, Palma G, Poli V, Palumbo S, Russolillo V, Cioffi S, et al. Tranexamic acid therapy in pediatric cardiac surgery: A single-center study. Ann Thorac Surg 2012; 94:1302-1306
23. Faraoni D, Willems A, Melot C, De Hert S, Van der Linden P. Efficacy of tranexamic acid in paediatric cardiac surgery: A systematic review and meta-Analysis. Eur J Cardiothorac Surg 2012; 42:781-786
24. Schouten ES, van de Pol AC, Schouten AN, Turner NM, Jansen NJ, Bollen CW. The effect of aprotinin, tranexamic acid, and aminocaproic acid on blood loss and use of blood products in major pediatric surgery: A meta-Analysis. Pediatr Crit Care Med 2009; 10:182-190
25. Zonis Z, Seear M, Reichert C, Sett S, Allen C. The effect of preoperative tranexamic acid on blood loss after cardiac operations in children. J Thorac Cardiovasc Surg 1996; 111:982-987
26. Grassin-Delyle S, Couturier R, Abe E, Alvarez JC, Devillier P, Urien S. A practical tranexamic acid dosing scheme based on population pharmacokinetics in children undergoing cardiac surgery. Anesthesiology 2013; 118:853-862
27. Grassin Delyle S, Abe E, Batisse A, Tremey B, Fischler M, Devillier P, et al. A validated assay for the quantitative analysis of tranexamic acid in human serum by liquid chromatography coupled with electrospray ionization mass spectrometry. Clin Chim Acta 2010; 411:438-443
28. Grassin-Delyle S, Tremey B, Abe E, Fischler M, Alvarez JC, Devillier P, et al. Population pharmacokinetics of tranexamic acid in adults undergoing cardiac surgery with cardiopulmonary bypass. Br J Anaesth 2013; 111:916-924
29. Williams GD, Bratton SL, Riley EC, Ramamoorthy C. Coagulation tests during cardiopulmonary bypass correlate with blood loss in children undergoing cardiac surgery. J Cardiothorac Vasc Anesth 1999; 13:398-404
30. Kojima T, Gando S, Morimoto Y, Mashio H, Goda Y, Kawahigashi H, et al. Systematic elucidation of effects of tranexamic acid on fibrinolysis and bleeding during and after cardiopulmonary bypass surgery. Thromb Res 2001; 104:301-307
31. Hoylaerts M, Lijnen HR, Collen D. Studies on the mechanism of the antifibrinolytic action of tranexamic acid. Biochim Biophys Acta 1981; 673:75-85
32. Longstaff C. Studies on the mechanisms of action of aprotinin and tranexamic acid as plasmin inhibitors and antifibrinolytic agents. Blood Coagul Fibrinolysis 1994; 5:537-542
33. Silva MM, Thelwell C, Williams SC, Longstaff C. Regulation of fibrinolysis by C-Terminal lysines operates through plasminogen and plasmin but not tissue plasminogen activator (tPA). J ThrombHaemost 2012; [Epub ahead of print]
34. Spahn DR, Cerny V, Coats TJ, Duranteau J, Fernandez-Mondejar E, Gordini G, et al. Management of bleeding following major trauma: A European guideline. Crit Care 2007; 11:R17
35. Witte S. The influence of the fibrinolytic system on the affinity of fibrinogen for the endothelial-plasma interface. Thromb Res 1988; 52:111-117
36. Sigaut S, Tremey B, Ouattara A, Couturier R, Taberlet C, Grassin-Delyle S, et al. Comparison of two doses of tranexamic acid in adults undergoing cardiac surgery with cardiopulmonary bypass. Anesthesiology 2013; [Epub ahead of print]
37. Staikou C, Paraskeva A, Drakos E, Anastassopoulou I, Papaioannou E, Donta I, et al. Impact of graded hypothermia on coagulation and fibrinolysis. J Surg Res 2011; 167:125-130
38. Journois D, Pouard P, Greeley WJ, Mauriat P, Vouhe P, Safran D. Hemofiltration during cardiopulmonary bypass in pediatric cardiac surgery. Effects on hemostasis, cytokines, and complement components. Anesthesiology 1994; 81:1181-1189; [discussion 1126A-1127A]..